Company Repro-Med Systems, Inc. OTC Bulletin Board
Equities
US7599101026
Medical Equipment, Supplies & Distribution
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Domestic Core
78.7
%
| 21 | 76.0 % | 22 | 78.7 % | +5.85% |
International Core
16.1
%
| 4 | 14.9 % | 5 | 16.1 % | +10.36% |
Novel Therapies
5.2
%
| 3 | 9.1 % | 1 | 5.2 % | -41.61% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
83.0
%
| 24 | 84.6 % | 24 | 83.0 % | +0.38% |
International
17.0
%
| 4 | 15.4 % | 5 | 17.0 % | +12.34% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Linda Tharby
CEO | Chief Executive Officer | 56 | 21-04-11 |
Thomas Adams
DFI | Director of Finance/CFO | 52 | 21-10-31 |
Brent Rutland
CTO | Chief Tech/Sci/R&D Officer | - | - |
Brian Case
CTO | Chief Tech/Sci/R&D Officer | - | 22-04-17 |
Chief Operating Officer | - | - | |
Kenneth Miller
PRN | Corporate Officer/Principal | - | 11-05 |
Miller Doug
PRN | Corporate Officer/Principal | - | 22-04-30 |
Brian Hertzog
PRN | Corporate Officer/Principal | - | 21-11-04 |
Rob Cannon
SAM | Sales & Marketing | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Cascella
BRD | Director/Board Member | 69 | 21-12-31 |
R. Fletcher
CHM | Chairman | 78 | 19-05-06 |
Edward Wholihan
BRD | Director/Board Member | 64 | 23-09-27 |
Shahriar Matin
BRD | Director/Board Member | 49 | 20-12-31 |
Joe Manko
BRD | Director/Board Member | 58 | 16-05-12 |
Linda Tharby
CEO | Chief Executive Officer | 56 | 21-04-11 |
Donna French
BRD | Director/Board Member | 59 | 21-05-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 49,184,727 | 42,850,685 ( 87.12 %) | 0 | 87.12 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.84% | 40.7B | |
+24.51% | 32.25B | |
+3.43% | 26.53B | |
+15.25% | 25.02B |